Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Immunotherapy Advances|April 23, 2025
Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitorsLouis Waeckel, Chloé Talon, Mathilde Barrau, et al.
Immunotherapy Advances|April 16, 2024
Recent advances in immunotherapies against infectious diseasesDharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances|June 22, 2026
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responsesAkhil Shukla, Mohammad Moradzad, Akouavi Julite Irmine Quenum, et al.
Immunotherapy Advances|August 20, 2026
Optimized procurement of cancer-reactive T-cell receptors from clinical samplesMarine E Caillaud, Cristina Rius, Théo Morin, et al.
Immunotherapy Advances|August 2, 2022
CSF1R defines the mononuclear phagocyte system lineage in human blood in health and COVID-19Theo W Combes, Federica Orsenigo, Alexander Stewart, et al.
Immunotherapy Advances|August 3, 2022
Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxinA Ammon, L Mellenthin, C Emmerich, et al.
Immunotherapy Advances|August 3, 2022
Peanut oral immunotherapy: current trends in clinical trialsSimone Reinwald, Jennifer M Rolland, Robyn E O'Hehir, et al.
Immunotherapy Advances|August 3, 2022
Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapyDayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, et al.
Immunotherapy Advances|August 3, 2022
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetesD Tatovic, M A McAteer, J Barry, et al.
Immunotherapy Advances|August 3, 2022
Upcoming immunotherapeutic combinations for B-cell lymphomaPatrick Greve, Friederike A G Meyer-Wentrup, Victor Peperzak, et al.
Pageof 16